project id: TCGA-PAAD; case submitter id: TCGA-2J-AABP; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.86; rna integrity number: 9.0; age at index: 58; days to birth: -21484; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 21484; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 463.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8020/3; primary diagnosis: Carcinoma, undifferentiated, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tail of pancreas; synchronous malignancy: No; tissue or organ of origin: Tail of pancreas; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Yes; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 237; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-2J-AABP-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;